STEMLINE THERAPEUTICS INC - COM (STML)

CUSIP: 85858C107

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
8,358,969
Share change
+382,362
Total reported value
$163,817,361
Price per share
$19.60
Number of holders
67
Value change
+$3,468,000
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 85858C107?
CUSIP 85858C107 identifies STML - STEMLINE THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of STEMLINE THERAPEUTICS INC - COM (STML) as of Q4 2013

As of 31 Dec 2013, STEMLINE THERAPEUTICS INC - COM (STML) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,358,969 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, SAC Capital Advisors LP, BAKER BROS. ADVISORS LP, Ridgeback Capital Investments L.P., JANUS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, GOLDMAN SACHS GROUP INC, and EVENTIDE ASSET MANAGEMENT, LLC. This page lists 67 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.